Albert Liu
San Francisco Department of Public Health · albert.liu@sfdph.org · SFDPH Bridge HIV
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Albert Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:02 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07510048 · Combatting HIV Or Other STIs Early (CHOOSE)Westat · recruiting · HIV, STIs, STIs Prevention · study chair
- Ph2NCT06631365 · PrEPsmart 2-1-1 PilotPublic Health Foundation Enterprises, Inc. · unknown · HIV-1-infection · principal investigator
- N/ANCT05979714 · The Cheeky Study: A Novel Delivery System for CAB-RPV LAPublic Health Foundation Enterprises, Inc. · unknown · HIV Infections · principal investigator
- Ph1NCT03670355 · Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing TenofovirNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- N/ANCT03177512 · LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With MenPublic Health Foundation Enterprises, Inc. · completed · HIV, Sexually Transmitted Diseases, Risk Reduction · study chair
- Ph1NCT02419456 · Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048National Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- N/ANCT02371525 · Enhancing PrEP in Community Settings (EPIC)University of California, San Francisco · completed · HIV · principal investigator
- N/ANCT01632995 · Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) ClinicsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph1NCT00903084 · Examining Hair to Determine Tenofovir ExposurePublic Health Foundation Enterprises, Inc. · completed · HIV · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Street PrEP: Expanding a Low-Barrier PrEP Delivery Model Among People Who Use Drugs and Experiencing Homelessness in San FranciscoR01DA065104 · NIDA · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2026 · $588,669 awarded in 2026Same name and institution; not confirmed by an ID
- TakeMeHome: Innovative Strategies to Integrate PrEP and DoxyPEP Navigation into a Nationwide Home HIV/STI Self-Testing Program in the United StatesR01MH140708 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2026 · $610,601 awarded in 2026Same name and institution; not confirmed by an ID
- The Bridge Clinic: Optimizing Injectable PrEP Delivery for Transgender and Non-Binary PeopleR01MH132488 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2023 to 2026 · $519,514 awarded in 2026Same name and institution; not confirmed by an ID
- PrEPmate 211: Developing a mobile app to support the safe and effective use of on-demand PrEP among MSM in the USR34MH121139 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2019 to 2021 · $190,454 awarded in 2021Same name and institution; not confirmed by an ID
- LYNXU19HD089881 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2016 to 2017 · $183,630 awarded in 2017Grant number is on one of their registry trials
- Enhancing PrEP in Community Settings (EPIC)R01MH095628 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2011 to 2015 · $467,119 awarded in 2015Same name and institution; not confirmed by an ID
- Hair as a Biomarker of Tenofovir Prophylactic ExposureR21MH085598 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · fiscal years 2009 to 2010 · $181,212 awarded in 2010Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:02 UTC. The ranking covers the 200 most relevant of 405 PubMed records, and a shared surname and initials can bring in a namesake. All 405 on PubMed
- 4,251 citationsRCR 138.3
- Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.Sci Transl Med · 2012865 citationsRCR 32.1
- Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.N Engl J Med · 2023818 citationsRCR 112.1
- Development and cross-sectional validation of the Childhood Asthma Control Test.J Allergy Clin Immunol · 2007754 citationsRCR 24.9
- 748 citationsRCR 20.7
- Oral immunotherapy for treatment of egg allergy in children.N Engl J Med · 2012583 citationsRCR 18.5
- Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.J Allergy Clin Immunol · 2015418 citationsRCR 16.0
- Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth.Sci Transl Med · 2018381 citationsRCR 18.6
- Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.Antimicrob Agents Chemother · 2017259 citationsRCR 12.8
- Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.J Allergy Clin Immunol · 2013236 citationsRCR 8.7